A life of excellence, nourished.
Jason Fee, MS, RDN, LDN · GLP-1 Specialist · Oncology Nutrition · Executive Nutrition Consultant · Published Author. Evidence-based. Radically personal.
I'm Jason Fee — a Registered Dietitian (MS, RDN, LDN) specializing in oncology nutrition, GLP-1 therapy, longevity medicine, and executive nutrition consulting. I hold a Master of Science degree from James Madison University and have spent years working at the intersection of evidence-based clinical nutrition and the deeply personal experience of eating through life's most demanding moments.
My work sits at the intersection of clinical rigor and human reality. I've spent years helping cancer patients nourish their bodies through chemotherapy, immunotherapy, radiation, and surgery — and helping high-performing executives build nutrition strategies that survive the demands of real life. As one of Florida's emerging GLP-1 clinical specialists, I help patients on Ozempic, Wegovy, and Mounjaro preserve muscle, manage side effects, and build sustainable long-term strategies.
My graduate research at James Madison University applied computer vision and AI to dietary assessment — a field I was working in before "AI in healthcare" became a LinkedIn headline.
═ized nutritional support for patients navigating cancer diagnosis, active treatment, and survivorship — with deep clinical experience in chemotherapy, immunotherapy, radiation, and surgery nutrition.
Clinical guidance for patients on semaglutide, tirzepatide, and retatrutide — focused on muscle preservation, protein strategy, managing GI side effects, and sustainable long-term outcomes the prescriber doesn't cover.
Private consulting for C-suite executives and high-performing leaders who require precision nutrition strategy — performance-grade guidance, not wellness platitudes.
Evidence-based frameworks for hospital systems and health networks on RDN workforce strategy, clinical nutrition program investment, and compensation advocacy.
Years of bedside and outpatient oncology nutrition experience — helping patients nourish their bodies through chemotherapy, immunotherapy, radiation, surgery, and survivorship.
Private nutrition consulting for high-performance executives and professionals — precision strategy tailored to real-world demands, schedules, and performance goals.
The Cancer Treatment Nutrition Guide — clinical-grade, evidence-based nutrition guidance for patients and caregivers through chemo, radiation, immunotherapy, and recovery. Available on Amazon.
MS thesis at James Madison University applying computer vision and machine learning to dietary intake assessment — before AI in healthcare was a buzzword.
Whether you're navigating a cancer diagnosis, optimizing your GLP-1 journey, building longevity, or performing at the executive level — clinical nutrition should meet you where you are.
═ized nutrition support across the cancer continuum — from diagnosis through treatment and survivorship.
Clinical nutrition support for patients on semaglutide, tirzepatide, and retatrutide — what your prescriber doesn't have time to cover.
Precision nutrition to extend healthspan, optimize metabolic function, and perform at your best — today and for decades ahead.
Concierge-level nutrition consulting for high-performing professionals who understand that optimal health is a strategic advantage.
Evidence-based guides written from years at the oncology bedside and GLP-1 clinical practice. No wellness myths. No false promises. Just science — and practical, actionable guidance.
The science of GLP-1, GIP & glucagon receptor agonists — including semaglutide, tirzepatide, and retatrutide. Evidence-based strategies for protein intake, resistance training, micronutrient gaps, dosing philosophy, and long-term weight maintenance. What your prescriber doesn't have time to explain.
The only clinical-grade nutrition guide written specifically for cancer patients and their caregivers. Covers all treatment types, 14 symptom toolkits, food safety, and patient worksheets. Written from years at the oncology bedside.
GLP-1 medications can be remarkably effective — but 25–39% of weight lost may come from lean muscle mass. This calculator estimates your personal muscle loss risk and the daily protein target needed to protect it, based on clinical evidence from the STEP and SURMOUNT trials.
Protein targets are based on lean body mass (LBM), not total body weight. Range: 1.6 g/kg LBM (minimum to prevent loss) to 2.2 g/kg LBM (optimal preservation with resistance training). Muscle loss estimate extrapolated from trial body composition data.
Most health systems underinvest in clinical nutrition — not because leadership doesn't value it, but because no one has made the case compellingly enough. That's where I come in.
I work with hospital systems, health networks, and executive leadership teams to build evidence-based frameworks for nutrition program investment: workforce strategy, RDN compensation advocacy, clinical program design, and alignment with organizational mission.
My compensation advocacy work draws on primary benchmarking analysis across national RDN salary data, workforce pipeline modeling, clinical ROI scenario building, and mission-alignment strategy — including frameworks connecting nutrition investment to whole-person care models and value-based care. This isn't advocacy by opinion. It's advocacy by evidence.
Benchmarking against BLS data, regional markets, and peer clinical roles — with three-scenario financial modeling and actionable pay architecture recommendations.
Pipeline analysis, retention projections, and risk modeling around ACEND enrollment declines and inpatient dietetics workforce contraction.
Conservative, base, and optimistic projections for malnutrition identification revenue, LOS reduction, and readmission avoidance tied to RDN investment.
Connecting nutrition investment to your organization's stated values — whole-person care, workforce wellbeing, and long-term clinical outcomes.
Evidence-based speaking engagements for clinical leadership, medical staff, and executive audiences.
Pipeline analysis, retention modeling, and compensation frameworks that position your organization as an employer of choice for top clinical nutrition talent.
End-to-end design of clinical nutrition programs for oncology service lines — from staffing ratios to care protocols to outcome metrics.
Financial models connecting RDN investment to malnutrition identification revenue, LOS reduction, readmission avoidance, and audit risk mitigation.
As GLP-1 medications create a new wave of clinical nutrition demand, I help systems build the RDN infrastructure to capture that opportunity — and reduce downstream costs.
An organization publicly committed to whole-person care was compensating licensed nutrition experts 20–30% below adjacent allied health roles, with no formal case ever made to leadership. The resulting framework projected $94.1M in clinical value against ~$750K in annual compensation correction cost.
All identifying details anonymized for consulting engagements.
Estimate the projected clinical value of strategic RDN investment for your health system. Based on published malnutrition identification revenue, LOS reduction data, and readmission avoidance benchmarks.
Clinical value projections based on malnutrition identification revenue (DRG coding), LOS reduction, and readmission avoidance benchmarks from peer-reviewed literature. All figures are modeling estimates for planning purposes only. Individual results vary by case mix, documentation practices, and organizational context.
Clinical perspectives on oncology nutrition, GLP-1 therapy, longevity, and the science of nourishing a life well-lived.
The trials don't lie: tirzepatide produces remarkable weight loss. What they don't tell you at the pharmacy is how much of that weight is lean mass — and what happens to your metabolism when it's gone. A clinical breakdown of the muscle loss problem, the resistance training prescription that prevents it, and why protein timing matters more than total protein on a GLP-1.
Immunotherapy side effects create a different nutritional landscape than chemotherapy — and most patients aren't prepared for it.
24.2% mean body weight reduction at 48 weeks. The triple agonist data is extraordinary — and the clinical implications are significant.
How to structure your meals to reduce chronic inflammation, support metabolic health, and extend your healthspan.
"Working with Jason during my breast cancer treatment was transformative. I finally had a clear, personalized plan — not generic advice. My energy levels during chemo were completely different."
"I've been on Ozempic for 8 months and losing muscle was my biggest fear. The GLP-1 guide was the most practical, science-based resource I found — and the consulting session changed my whole approach."
"As a CEO, I've worked with doctors, trainers, and coaches — but no one addressed my nutrition with this level of clinical rigor and personalization. My labs have never looked better."
Currently, consultations are offered on a private-pay basis. This allows me to spend more time with each client and provide truly individualized care without insurance billing constraints. Many clients use HSA/FSA accounts. I'm happy to provide a superbill for potential out-of-network reimbursement upon request.
All private consulting sessions are conducted via secure video call, allowing me to work with clients anywhere in the country. If you're local to the Orlando / Celebration, FL area, in-person sessions may be available upon request.
A lot — and it's likely more than your prescriber has time to cover. I specialize in the nutrition side of GLP-1 therapy: building a protein strategy to preserve muscle (which 25–39% of GLP-1 weight loss can be), managing GI side effects, dosing-day meal timing, navigating plateaus, alcohol and fasting interactions, and building a sustainable long-term approach once you reach your maintenance phase.
Absolutely — in fact, nutritional support during treatment is one of the most evidence-backed interventions for quality of life, treatment tolerance, and clinical outcomes. I work in close coordination with your oncology team and am trained to understand the nuances of each treatment type and its nutritional implications.
System consulting engagements typically begin with an organizational discovery call, followed by a customized scope of work. I can deliver compensation benchmarking analyses, clinical ROI models, workforce pipeline assessments, and leadership presentations — all adapted to your system's size, mission, and specific nutrition program challenges. Reach out via the contact form to start the conversation.
Select a consultation type and choose a time that works for you. All sessions via secure video call. Calendly integration coming soon — reach out via contact form to book now.
You'll receive a confirmation with your secure video link.
Whether you have questions about a service, want to discuss your specific situation before booking, are interested in healthcare system consulting, or have a media or speaking inquiry — I'd love to hear from you.